Skip Navigation

A Phase 2 Single-Arm Study of M6620 in Combination with Irinotecan in Patients with Progressive TP53 Mutant Gastric and Gastro-Esophageal Junction Cancer

Brief Summary

Type:
Esophageal

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03641313

Study #:
STUDY00146188

Start Date:
Sep 17, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03641313

View Complete Trial Details & Eligibility at ClinicalTrials.gov